
Sign up to save your podcasts
Or


Gone are the days of low-carb diets and strict exercise routines— instead, millions of Americans are turning to Ozempic! Though the drug was initially used to help diabetics manage their blood sugar levels, it’s now toted as a reliable way to treat obesity. So what are the long-term effects of this drug?
What could happen to people taking it who aren’t considered overweight in the first place? Sean and Rachel are joined by board-certified radiologist Dr. Nicole Saphier and mammography technician Erin, who’s currently using Ozempic, to discuss how the drug causes significant weight loss, the possible side effects and long-term impacts that could come with it, and why it’s become such a massive fad amongst Americans.
Follow Sean & Rachel on Twitter: @SeanDuffyWI & @RCamposDuffy
Learn more about your ad choices. Visit podcastchoices.com/adchoices
By FOX News Podcasts4.2
542542 ratings
Gone are the days of low-carb diets and strict exercise routines— instead, millions of Americans are turning to Ozempic! Though the drug was initially used to help diabetics manage their blood sugar levels, it’s now toted as a reliable way to treat obesity. So what are the long-term effects of this drug?
What could happen to people taking it who aren’t considered overweight in the first place? Sean and Rachel are joined by board-certified radiologist Dr. Nicole Saphier and mammography technician Erin, who’s currently using Ozempic, to discuss how the drug causes significant weight loss, the possible side effects and long-term impacts that could come with it, and why it’s become such a massive fad amongst Americans.
Follow Sean & Rachel on Twitter: @SeanDuffyWI & @RCamposDuffy
Learn more about your ad choices. Visit podcastchoices.com/adchoices

153,248 Listeners

4,216 Listeners

946 Listeners

1,719 Listeners

860 Listeners

26 Listeners

801 Listeners

68 Listeners

868 Listeners

1,612 Listeners

61,892 Listeners

619 Listeners

382 Listeners

49 Listeners

79 Listeners

867 Listeners

498 Listeners

0 Listeners

12 Listeners

17 Listeners

12 Listeners